Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 86 results found. Search for [ Pankaj R Patel ]

Results 1 to 21 of 86
PB Jayakumar
November 3, 2020
Zydus today said it has filed an Investigational New Drug (IND) application for 'ZYIL1', an oral drug candidate, that has found to be effective in pre-clinic studies to control inflammation in COVID-19 related diseases


PTI
September 22, 2020
A vaccine is definitely needed to control the spread of this disease, but the vaccine alone is not enough, and other efforts such as social distancing, wearing mask, isolating and testing people will continue to remain important


BusinessToday.In
August 7, 2020
Coronavirus vaccine news update: Serum Institute of India would have exclusive rights for the supply of the Novavax COVID-19 vaccine in India


BusinessToday.In
August 5, 2020
Coronavirus vaccine news update: The Phase II trial will evaluate the humoral and cellular immune response for the coronavirus vaccine candidate, keeping in line with the current global protocols


Joe C Mathew
August 3, 2020
Indian vaccine manufacturers are waiting for a vaccination plan from the government so that they can set aside stocks of vaccines when they are approved for production


BusinessToday.In
July 15, 2020
Coronavirus vaccine update: In the human trials, Zydus will enroll over 1,000 subjects across multiple clinical study sites in the country


BusinessToday.In
July 13, 2020
Bharat Biotech is developing the vaccine in collaboration with the ICMR. It has started human trials on its vaccine candidate, 'Covaxin', which is India's first indigenous COVID-19 vaccine. It is working to develop an initial capacity of 200 million vials of the vaccine


BusinessToday.In
July 10, 2020
Coronavirus vaccine news update: Serum Institute of India that is producing around four vaccine candidates including the Oxford University-AstraZeneca coronavirus candidate has said that it is expected to launch a candidate by the end of six months


BusinessToday.In
July 6, 2020
The company said it will conduct a study to evaluate the efficacy and safety of Desidustat tablets for the management of COVID-19 patients


Sumant Banerji
June 24, 2020
CAIT has been at the forefront of an anti Chinese products campaign in India following the spread of coronavirus that originated in Wuhan province in China and has ravaged global economy including India


Sumant Banerji
June 24, 2020
In many sectors like electronics including smartphones, pharmaceuticals, renewable energy and automobiles, Indian industries remain heavily reliant on imports from China that cannot be substituted either by local production or from any other source overnight


BusinessToday.In
New Delhi, May 21, 2020
Earlier, the company had partnered with ICMR to be better equipped against infectious disease outbreaks, and help people, who are at high risk, particularly in distant, remote areas of the country


PB Jayakumar and E Kumar Sharma
New Delhi, April 28, 2020
Seven Indian firms are among those hunting for a vaccine to tame Covid-19. Here is how the projects are progressing


BusinessToday.In
New Delhi, February 18, 2020
India emerges as world's 5th largest economy, overtakes UK and France, says reportIndia emerged as the world's fifth largest economy by overtaking the UK and France in 2019, says a report. A US-based think tank World Population Review in its report said that India is developing into an open-market economy. The report further said that in purchasing power parity (PPP) terms, India's GDP (PPP) is USD 10.51 trillion, exceeding that of Japan and Germany. Coronavirus: Paracetamol pri...


BusinessToday.In
February 18, 2020
Coronavirus outbreak latest: The pharma sector in India could possibly be faced with shortages in finished drug formulations from April in case the supply chains are not restored by the first week of March.


BusinessToday.In
New Delhi, February 15, 2020
The first approach deals with development of a DNA vaccine against the major viral membrane protein responsible for the cell entry of the novel coronavirus, now called COVID-19


PTI
New Delhi, December 22, 2019
The executives stressed on the need for Indian manufacturing to become globally competitive and join global value chain as the key ingredients for becoming a $5 trillion economy


E Kumar Sharma
New Delhi, November 25, 2019
A number of biologics with huge markets are going off-patent in the US. Do Indian pharmaceutical companies have it in them to play this high-cost, high-risk game of launching biosimilars?


PTI
July 26, 2019



PB Jayakumar
New Delhi, July 22, 2019
Zydus Cadila, India's fourth-largest drug company by revenue, is banking big on research of new drugs, even though others have bowed out. Zydus expects the new drug business to grow to Rs 3,500 crore in four-five years


PAGES 1 OF 5  12345